Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Shukra Pharmaceuticals Annual Report

Shukra Pharmaceuticals Ltd has filed its 32nd Annual Report for the financial year 2025-26 as mandated by SEBI (LODR) regulations. The document covers the company's annual activities.

Source

BSE filing, NSE: SHUKRAPHAR. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Shukra Pharmaceuticals Ltd: key numbers

Share price
₹71.89
Market cap
₹3,181 Cr
Revenue (annual)
₹56.73 Cr
Net profit (annual)
₹22.06 Cr
P/E (TTM)
93.6×Sector 46.1×
Promoter holding
51.15%+0.19% QoQ
FII holding
0.43%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shukra Pharmaceuticals Ltd

All →

Other annual report announcements

All →